HAYA Therapeutics SA Revenue and Competitors
Estimated Revenue & Valuation
- HAYA Therapeutics SA's estimated annual revenue is currently $10.2M per year.
- HAYA Therapeutics SA's estimated revenue per employee is $155,000
Employee Data
- HAYA Therapeutics SA has 66 Employees.
- HAYA Therapeutics SA grew their employee count by 20% last year.
HAYA Therapeutics SA's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Business Officer | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | Senior Director, Biomarkers | Reveal Email/Phone |
4 | Director Biology and Functional Genomics | Reveal Email/Phone |
5 | Senior Director, Biomarkers | Reveal Email/Phone |
6 | Director, Computational Biology | Reveal Email/Phone |
7 | Preclinical / Regulatory Project Manager | Reveal Email/Phone |
8 | Preclinical Project Manager | Reveal Email/Phone |
9 | Project Lead - Oncology | Reveal Email/Phone |
10 | Bioinformatics Scientist | Reveal Email/Phone |
HAYA Therapeutics SA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is HAYA Therapeutics SA?
HAYA Therapeutics is a Swiss-based pre-clinical early stage biopharmaceutical company dedicated to treating fibrotic diseases through the discovery and development of innovative targeted first-in-class RNA-based therapeutics, with a specific focus on long noncoding RNAs. Our vision is to be the first company and a world leader in translating long noncoding RNA discoveries into breakthrough therapies to monitor and treat patients with debilitating diseases caused by fibrosis.
keywords:N/A
N/A
Total Funding
66
Number of Employees
$10.2M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator